Diogo R. Feleciano, PhD

Dr. Diogo R. Feleciano holds a PhD in biochemistry from the Freie Universität Berlin. Dr. Feleciano is the Co-Founder and CSO of Booster Therapeutics and is an entrepreneur passionate about translating science into transformative treatments. He has been leading the company since its inception in 2020, and in 2024, raised a $15M from Apollo Health Ventures and Novo Holdings. Booster is a preclinical-stage biotech company developing oral, brain-penetrant small molecules that restore proteasome function to treat Parkinson’s Disease.

Previously, Dr. Feleciano completed his biochemistry degree at the University of Coimbra in Portugal in 2013. He then moved to the UK to work at Imperial College London in the ocular field. In 2015, he moved to Berlin, Germany, to pursue his PhD, focusing on the impact of proteasome function during aging and neurodegenerative diseases. In 2019, he became an EiR at Apollo, which eventually led to the founding of Booster.